IMH Podcast
13 Oct 2021
Patient Journeys: Overcoming Graves' Disease
playlist_add
Join your host Danny Urbinder, along with with Denise Furness, as she describes her Graves' disease journey from debilitating disease progression to becoming symptom-free through an Integrative Medicine approach, using nutrients, diet, herbs and stress management techniques.
Graves’ disease is an autoimmune disease that affects the thyroid and is the most common cause of hyperthyroidism. Medical treatment of Graves' disease includes antithyroid drugs, radioactive iodine and thyroidectomy.
Guest experts:
- Professor Marc Cohen
- Keonie Moore
- Tara Nelson
For more information about this episode, including show notes visit: https://imh.education/courses/graves-disease-with-dr-denise-furness/
or download the IMH App. Available in the App Store and Google Play.
Follow us:
DISCLAIMER
The information provided on the Integrative Medicine Hub is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you have read here raises questions or concerns regarding your health.
More episodes from IMH Podcast
23 Oct 2022
Patient Journeys: Overcoming Multiple Sclerosis with Terry Wahls
There has been a steady rise in autoimmune disease throughout industrialised societies over the last 30 years. Almost 4.5% of the world’s population is affected by one of more than 80 different autoimmune diseases.
To add to these already alarming statistics, recent studies have revealed that the incidence of autoimmune diseases worldwide is increasing at a rate of 19% per year.
While we know that numerous predisposing genetic risk factors have been identified, these only account for a fraction of the overall incidence of autoimmune diseases.
There are studies pointing to a strong influence of environmental and lifestyle factors, but translating this into a meaningful therapeutic model is a challenge, especially under the current, prevailing medical paradigm.
Nevertheless, there are those who have pioneered this field of research and, through their personal and professional endeavours, have made it all but impossible to ignore how profound an impact diet, lifestyle and mindset can have when faced with seemingly intractable conditions.
Dr Terry Wahls is a clinical professor of medicine at the University of Iowa. In 2000, she was diagnosed with relapsing remitting multiple sclerosis and from that point, began to steadily decline. Because of her academic medical training, Terry began a research journey that eventually led her to investigate these under-explored factors and from this she developed a treatment plan that would help restore her health.
Today, Dr Terry Wahls is a teacher and mentor to millions of people around the world who are seeking more effective ways to treat multiple sclerosis and other progressive health problems.
Her story is truly inspirational and we are so fortunate to have Terry share this on the IMH Patient Journeys podcast.
References:
* Jamka M, et.al. The Effect of the Paleolithic Diet vs. Healthy Diets on Glucose and Insulin Homeostasis. J Clin Med. 2020;9(2):296.
* Challa HJ, Bandlamudi M, Uppaluri KR. Paleolithic Diet. [Updated 2022 May 2].
* Abbott RD, et.al. Efficacy of the Autoimmune Protocol Diet as Part of a Multi-disciplinary, Supported Lifestyle Intervention for Hashimoto's Thyroiditis. Cureus. 2019;11(4)
* Gauree G. et.al. Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease, Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2054–2060
* Cecilio LA, et.al. The prevalence of HLA DQ2 and DQ8 in patients with celiac disease, in family and in general population. Arq Bras Cir Dig. 2015 Jul-Sep;28(3):183-5.
* Mangalam, Ashutosh et.al. (2009). HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice. Journal of immunology.
* Santoro L, et.al. Looking for celiac disease in Italian women with endometriosis: a case control study. Biomed Res Int. 2014;2014
* Małgorzata Królik, et.al. Possible effect of the HLA-DQ2/DQ8 polymorphism on autoimmune parameters and lymphocyte subpopulation in recurrent pregnancy losses, Journal of Reproductive Immunology, Volume 149, 2022,
* Garcia J, et.al. Social isolation and connectedness as determinants of well-being: Global evidence mapping focused on LGBTQ youth. Glob Public Health. 2020 Apr;15(4):497-519. doi: 10.1080/17441692.2019.1682028. Epub 2019 Oct 28.
* Rothman, Emily F.et.al. "The Prevalence of Sexual Assault Against People Who Identify as Gay, Lesbian, or Bisexual in the United States: A Systematic Review". Trauma, Violence, & Abuse. 12 (2): 55–66.
* Brenton JN, et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637-644.
playlist_add
23 Jun 2022
Toxic Crisis and Solutions with Dr Joe Pizzorno
It’s been 60 years since Rachel Carson wrote her seminal book, Silent Spring, in which she sounded the warning that, through the wholesale use of man-made chemicals, we were destroying the biosphere and ourselves along with it.
Fast forward to 2022 and, not only have we failed to heed her sobering message, we have in fact severely exacerbated the problem with exponential growth in novel chemicals.
According to the European Chemicals Agency, there are more than 144,000 man-made chemicals in existence. The US Department of Health estimates that 2,000 new chemicals are being released every year.
The World Health Organisation estimates that 12 million people, that’s one in 4, die every year from diseases caused by 'air water and soil pollution, chemical exposures, climate change and ultraviolet radiation, all of which result from human activity.
While it is now impossible to completely avoid these toxicants, we can take steps to limit our exposure while also ensuring our capacity to metabolise and detoxify them is optimised.
To provide us with a deeper understanding of this urgent issue and what we can do about it we invited Dr Joe Pizzorno to the podcast. Many of the listeners will know Dr Pizzorno as a pioneer and living legend in the world of naturopathic and functional medicine. Dr Pizzorno was the founding president of Bastyr University and is an author, researcher, expert spokesman, and editor-in-chief of PubMed-indexed Integrative Medicine: A Clinician’s Journal.
He was appointed by Presidents Clinton and Bush to 2 prestigious government commissions to advise Congress on how to integrate natural medicine into healthcare. Dr Pizzorno is also the chair of IFM’s Board of Directors.
In recent years, Dr Pizzorno has focused his attention on the research on toxins and toxicants and their effect on human health.
*References:*
* Joseph Pizzorno, The Toxin Solution: How Hidden Poisons in the Air, Water, Food, and Products We Use Are Destroying Our Health--And What We Can Do to Fix It, 22 May 2017, HarperCollins US; 1st edition
* Walter J. Crinnion, Joseph E. Pizzorno Jr. ND, Clinical Environmental Medicine: Identification and Natural Treatment of Diseases Caused by Common Pollutants, July 9, 2018, 1st Edition, Elsevier; 1st edition
* Frederick S. vom Saal, et.al. Corrigendum to “Obesity III: Obesogen assays: Limitations, strengths, and new directions” [Biochem. Pharmacol. 199 (2022) 115014], Biochemical Pharmacology, Volume 202, 2022, 115145, ISSN 0006-2952, https://doi.org/10.1016/j.bcp.2022.115145.
* Heindel JJ, Howard S, Agay-Shay K, et al. Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015] [published online ahead of print, 2022 Jun 14]. Biochem Pharmacol. 2022;202:115144. doi:10.1016/j.bcp.2022.115144
* Frederick vom Saal, et.al. Obesity II: Establishing causal links between chemical exposures and obesity, Biochemical Pharmacology, Volume 199, 2022, 115015, ISSN 0006-2952, https://doi.org/10.1016/j.bcp.2022.115015.
* Frederick S. vom Saal, et.al. Obesity III: Obesogen assays: Limitations, strengths, and new directions, Biochemical Pharmacology, Volume 199, 2022, 115014, ISSN 0006-2952, https://doi.org/10.1016 j.bcp.2022.115014.
* Vom Saal FS, et.al. Update on the Health Effects of Bisphenol A: Overwhelming Evidence of Harm. Endocrinology. 2021;162(3):bqaa171. doi:10.1210/endocr/bqaa171
* Frederick S. vom Saal, et.al. Sex-biased impact of endocrine disrupting chemicals on behavioral development and vulnerability to disease: Of mice and children, Neuroscience & Biobehavioral Reviews, Volume 121, 2021, Pages 29-46, ISSN 0149-7634, https://doi.org/10.1016/j.neubiorev.2020.11.015.
playlist_add
16 Jun 2022
Rethinking Chronic Pain
While there have been scientific advances in the understanding of the neurophysiology of pain, we need to recognise that this has largely been based on a biomedical concept that struggles with the subjective and psychosocial nature of chronic pain.
The scientific forces that have driven our understanding of pain since the early 19th Century have largely viewed pain as an expression of an identifiable disease process resulting from tissue injury, nerve injury or a sensitised nervous system.
The biomedical model of pain has given rise to a massive global pain management drug market which includes non-steroidal anti-inflammatories, corticosteroids, acetaminophen and opioids. The global opioids market size alone was valued at $4.4 billion in 2020 and, with a current surge in demand, is projected to reach $6.1 billion by 2030.
A recent US study from May 2021 found that the prevalence of chronic pain is increasing for all demographics of adults, but especially for people from lower socioeconomic backgrounds. The research also found associations between people’s mental and physical health and a higher prevalence of chronic pain.
This finding supports the biopsychosocial model of pain which recognises physical symptoms as the outcome of a dynamic relationship, not only between mind and body, but among mind, body, and society.
Most research supports the effectiveness of a biopsychosocial approach and frequently finds that multi-disciplinary, multi-modal treatments give good outcomes in the treatment of chronic pain. And, while its effectiveness is becoming more widely accepted, its incorporation into clinical practice is still limited.
To provide us with a better understanding we asked Ananda Mahony to join us on the podcast.
Ananda is a naturopath with post-graduate qualifications in Nutrition and a Masters in Pain Management. She is experienced in all areas of general naturopathic practice however, over the last 6 years Ananda has been working extensively with clients experiencing persistent pain. Her interest in pain management stemmed from the observation that patients were not getting good results using standard naturopathic and medical approaches, as well as an innate curiosity about what underpinned their pain and how to work more effectively with it. Ananda incorporates aspects of pain education, nutrition, naturopathy, lifestyle and self-care, working in with patients’ existing persistent pain health care team.
*References:*
Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(1):13–23. doi:10.1001/jamapsychiatry.2021.2669
https://www.vox.com/science-and-health/2018/5/17/17276452/chronic-pain-treatment-psychology-cbt-mindfulness-evidence
The Lancet. Rethinking chronic pain. Lancet. 2021;397(10289):2023. doi:10.1016/S0140-6736(21)01194-6
playlist_add